Protara Therapeutics - 53 Year Dividend History | TARA
Historical dividend payout and yield for Protara Therapeutics (TARA) since 1971. The current TTM dividend payout for Protara Therapeutics (TARA) as of November 20, 2024 is $0.00. The current dividend yield for Protara Therapeutics as of November 20, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Drug Manufacturing |
$0.047B |
$0.000B |
|
Protara Therapeutics Inc. is committed to identifying and advancing transformative therapies for rare and specialty diseases. The company's portfolio includes, TARA-002, an investigational cell therapy being developed for the treatment of lymphatic malformations, and intravenous Choline Chloride, an investigational phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease. Protara Therapeutics Inc., formerly known as ArTara Therapeutics, is based in NEW YORK, United States.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
